
Sign up to save your podcasts
Or


We discuss the first interim results of a novel intravitreal gene therapy agent, 4D-150, with Dr. Arshad Khanani of Sierra Eye Associates and the University of Nevada Reno School of Medicine.
By Retina Synthesis4.5
88 ratings
We discuss the first interim results of a novel intravitreal gene therapy agent, 4D-150, with Dr. Arshad Khanani of Sierra Eye Associates and the University of Nevada Reno School of Medicine.

43 Listeners

18 Listeners

97 Listeners

5 Listeners

6,068 Listeners

4 Listeners

21 Listeners

10 Listeners

50 Listeners

11 Listeners

19 Listeners

0 Listeners

1 Listeners

18 Listeners

0 Listeners